Nitrogenous bisphosphonates may reduce the risk of endometrial cancer by almost 50 percent, a large study suggests. The endometrial cancer incidence rate in the cohort of 29,254 women was 8.7 vs. 17.7/10,000 person-years for ever vs. never users the study published in Cancer showed.